Edmond Lay

Partner
Full contact info

I provide strategic and practical advice to emerging and high-growth companies and investors, simplifying complex legal problems into clear and actionable choices.

Passions

Los Angeles Lakers (basketball)

All things coffee

Getting outdoors

Experience

Wugen Secures $115 Million Series C Financing

September 5, 2025

Cooley advised Wugen, a clinical-stage biotechnology company pioneering the next generation of allogeneic, off-the-shelf chimeric antigen receptor T-cell (CAR-T) therapies, on its $115 million Series C financing.

Read more

Related contacts

Tom Coll
Partner, San Diego
Jeremy Gentile
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Pauline Le
Associate, San Diego
Giselle Alexandria Valdez
Associate, San Diego
Charles Bair
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
Edmond Lay
Partner, San Diego
Timothy Shapiro
Partner, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Rebecca Ross
Special Counsel, Washington, DC
Richard Koch
Associate, Washington, DC
Walter Musgrave
Associate, San Diego
Sarah Oliai
Associate, Washington, DC
Patrick Sharma
Associate, Santa Monica
Alla Kagan
Paralegal Specialist, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie

June 30, 2025

Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Edmond Lay
Partner, San Diego
Charity Williams
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
W. Chad Shear
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Stacey A. Bradford
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Alexandria Ashour
Associate, San Diego
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Tony P. Guan
Associate, Santa Monica
Michelle Hunt
Associate
Emily Mok
Associate, Reston
Jonathan Perez-Reyzin
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Christopher Suhler
Associate, Colorado
Novak Topalovic
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Rubin Waranch
Associate, Colorado
Yuhan Wu
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Poseida Therapeutics Announces Agreement to Be Acquired by Roche for up to $1.5 Billion

November 26, 2024

Cooley advised Poseida Therapeutics, a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated nonviral treatments for patients with cancer, autoimmune and rare diseases, on its merger agreement to be acquired by Roche at a price of $9 per share in cash at closing, plus a non-tradable contingent value right to receive up to an aggregate of $4 per share in cash, payable upon achievement of specified milestones. The price payable at closing represents a total equity value of up to $1.5 billion and a premium of approximately 215% to Poseida’s closing share price on November 25, 2024. Cooley previously represented Poseida in its initial public offering, equity and debt transactions, and collaboration agreements, including its collaboration agreement with Roche.

Read more

Related contacts

Rowook Park
Partner, San Diego
Barbara Borden
Senior Counsel, San Diego
Julia Kim
Special Counsel, New York
Rajdeep Roger Bains
Associate, San Diego
Josh Himmelstern
Associate, San Diego
Elaine Huang
Associate, Palo Alto
Anne Luquette
Associate, San Francisco
Allie Pilmer
Associate, San Diego
Tom Coll
Partner, San Diego
Kenneth Krisko
Partner, Reston
Edmond Lay
Partner, San Diego
John Forrest
Associate, Boston
Jenny Ge
Associate, Santa Monica
Peter Adams
Partner, San Diego
Michael Bergmann
Partner, Washington, DC
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jeffrey J. Tolin
Partner, New York
Robert Eisenbach
Of Counsel, San Francisco
Maricel Mojares-Moore
Special Counsel, San Francisco
Dillon Martinson
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Alexandria Ashour
Associate, San Diego
Navya Dasari
Associate, New York
Nicollette R. Kirby
Associate, Washington, DC
Allison Kutner
Associate, New York
Calvin Lee
Associate, New York
Calvin Lee
Associate, New York
Breanna Qin
Associate, Palo Alto
Shelby Saunders
Associate, New York
Shaun (Tianjie) Wang
Associate, New York
Colleen R. Wellington-Caban
Associate, Washington, DC
Jack Whitaker
Associate, San Diego
Anna Anderson
Paralegal Specialist, London
Novak Topalovic
Associate, San Diego

Related Practices & Industries

Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger

September 9, 2024

Cooley advised Candid Therapeutics, a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, on its $370 million debut capital raise and three-way merger with Vignette Bio and TRC 2004.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Edmond Lay
Partner, San Diego
Ben Beerle
Partner, San Francisco
Leina Verrier
Associate, Santa Monica
Jack Whitaker
Associate, San Diego
Dillon Martinson
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Megan Browdie
Partner, Washington, DC
Nicholas Orr
Associate, Los Angeles
Sharon Connaughton
Special Counsel, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Linh Nguyen
Associate, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kate Walther
Paralegal Specialist, San Diego
John Sellers
Senior Counsel, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC

Related Practices & Industries

Radionetics Oncology Announces Strategic Agreement With Eli Lilly

July 1, 2024

Cooley advised Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein-coupled receptor (GPCR)-targeted radiopharmaceuticals to treat a broad range of solid tumors, on the formation of a strategic agreement with Eli Lilly to take forward Radionetics’ proprietary GPCR-targeting small molecule radiopharmaceuticals. Under the terms of the agreement, Radionetics received a $140 million up-front cash payment. Additionally, Lilly obtained the exclusive right to acquire Radionetics for $1 billion upon conclusion of an exercise period.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Charity Williams
Partner, San Diego
Jenny Ge
Associate, Santa Monica
Todd Gluth
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Howard Morse
Senior Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Kyle Hess
Associate, New York
Jonathan Kaufman
Associate, Palo Alto
Allison Kutner
Associate, New York
Edmond Lay
Partner, San Diego
Jeremy Gentile
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Breanna Qin
Associate, Palo Alto
Megan Drill
Associate, San Diego
Jack Whitaker
Associate, San Diego
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

View more

Admissions and credentials

California

Memberships and affiliations

American Bar Association (ABA)

San Diego County Bar Association

National Asian Pacific American Bar Association

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.